CLINICAL SIGNS AND LABORATORY MARKERS IN PREDICTING PROGRESSION TO AIDS IN HIV-1 INFECTED PATIENTS

被引:34
|
作者
MORFELDTMANSON, L
BOTTIGER, B
NILSSON, B
VONSTEDINGK, LV
机构
[1] STOCKHOLM CTY COUNCIL, DEPT BACTERIOL, CENT MICROBIOL LAB, STOCKHOLM, SWEDEN
[2] NATL BACTERIOL LAB, DEPT IMMUNOL, S-10521 STOCKHOLM, SWEDEN
[3] RADIUMHEMMET, DEPT CANC EPIDEMIOL & BIOSTAT, STOCKHOLM, SWEDEN
关键词
D O I
10.3109/00365549109075092
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In a prospective longitudinal study 89 men with HIV-1 infection were observed for a mean time of 51 months with regard to clinical signs and laboratory findings predictive of progression to AIDS/opportunistic infection (OI). In a bivariate regression analysis the clinical signs showing a significant relation to AIDS development were: dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis. The laboratory findings significantly associated with progression to AIDS were: decrease of the relative and absolute number of CD4 lymphocytes, decrease of the CD4/CD8 ratio, HIV p24 antigenaemia, lack of anti-HIV p24, elevated erythrocyte sedimentation rate, anaemia and elevated serum-beta-2-microglobulin. The relative number (%) of CD4 cells was found superior to the absolute number and the CD4/CD8 ratio. In a multivariate regression analysis decrease of CD4 lymphocytes and lack of anti-HIV p24 were independently associated with subsequent AIDS/OI development.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 50 条
  • [41] HIV-1 Envelope Evolution and Cognitive Dysfunction Progression in Puerto Rican Women Infected with HIV-1
    Vazquez-Santiago, F. J.
    Melendez, L. M.
    Plaud-Valentin, M.
    Wojna, V.
    Noel, R. J., Jr.
    Rivera-Amill, V.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 : S44 - S45
  • [42] HIV-1 control in battlegrounds: important host genetic variations for HIV-1 mother-to-child transmission and progression to clinical pediatric AIDS
    de Souza, Thais Louvain
    de Souza Campos Fernandes, Regina Celia
    Medina-Acosta, Enrique
    FUTURE VIROLOGY, 2012, 7 (07) : 659 - 678
  • [43] Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients
    Re, MC
    Furlini, G
    Vignoli, M
    Ramazzotti, E
    Zauli, G
    LaPlaca, M
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (02) : 230 - 232
  • [44] HIV-1 AND AIDS
    不详
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1993, 113 (03): : 115 - 115
  • [45] CLINICAL AND ELECTROPHYSIOLOGICAL STUDY OF 147 HIV-1 SEROPOSITIVE PATIENTS WITH AND WITHOUT AIDS
    SOLDATI, G
    CISTERNINO, MD
    FATTAPPOSTA, F
    MASSARA, MC
    PIERELLI, F
    JOURNAL OF PSYCHOPHYSIOLOGY, 1995, 9 (01) : 87 - 88
  • [46] Predicting susceptibility to secondary infection in HIV-1 infected people
    Rossen, RD
    Trial, JA
    Rubio, JA
    Siwak, EB
    Hamill, RI
    Rodriguez-Barradas, MC
    Breaux, K
    Birdsall, HH
    DeBakey, ME
    FASEB JOURNAL, 2005, 19 (05): : A1436 - A1436
  • [47] INACTIVATED HIV-1 IMMUNOGEN - IMPACT ON MARKERS OF DISEASE PROGRESSION
    MOSS, RB
    FERRE, F
    TRAUGER, R
    JENSEN, F
    DAIGLE, A
    RICHIERI, SP
    CARLO, DJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 : S21 - S27
  • [48] Evidence of HIV-1 genetic diversity among pregnant women with AIDS or infected with HIV-1 in Central Brazil
    Stefani, MMA
    Pereira, GAS
    Martelli, CMT
    Shindo, N
    Galvao-Castro, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) : 205 - 207
  • [49] Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS
    Villinger, F
    Brar, SS
    Brice, GT
    Chikkala, NF
    Novembre, FJ
    Mayne, AE
    Bucur, S
    Hillyer, CD
    Ansari, AA
    JOURNAL OF MEDICAL PRIMATOLOGY, 1997, 26 (1-2) : 11 - 18
  • [50] Erythema elevatum diutinum, a clinical entity to be considered in patients infected with HIV-1
    Martin, JIF
    Dronda, F
    Chaves, F
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 725 - 726